Viking Therapeutics Inc (VKTX)

NASDAQ HEALTHCARE
$32.75 -0.15% RSI 44 Neutral Add Alert

Moving Averages

SMA 200
$32.26
Price near

Company Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$4.05B
P/E Ratio
None
EPS
$-3.19
Beta
0.824
Dividend Yield
0.00%
52-Week High
$43.15
52-Week Low
$21.23

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 62.0
VRTX
Vertex Pharmaceuticals Inc
RSI 40.0
CRSP
CRISPR Therapeutics AG
RSI 41.0
MRNA
Moderna Inc
RSI 46.0
SRPT
Sarepta Therapeutics Inc
RSI 48.0
EDIT
Editas Medicine Inc
RSI 50.0

Data last updated: April 10, 2026 at 10:11 PM EDT

Track VKTX for free

Get e-mail RSI alerts when Viking Therapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert